GeneDx (WGS) News Today $95.83 -5.75 (-5.66%) Closing price 04:00 PM EasternExtended Trading$92.92 -2.91 (-3.04%) As of 07:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period GeneDx (NASDAQ:WGS) Price Target Raised to $80.00February 21 at 2:55 AM | americanbankingnews.comBrokerages Set GeneDx Holdings Corp. (NASDAQ:WGS) Price Target at $70.67February 21 at 1:33 AM | americanbankingnews.comGeneDx (NASDAQ:WGS) Trading Down 6.3% - Should You Sell?GeneDx (NASDAQ:WGS) Stock Price Down 6.3% - Time to Sell?February 20 at 2:14 PM | marketbeat.comGeneDx (NASDAQ:WGS) Given New $80.00 Price Target at The Goldman Sachs GroupThe Goldman Sachs Group lifted their target price on GeneDx from $70.00 to $80.00 and gave the company a "neutral" rating in a research note on Wednesday.February 20 at 9:57 AM | marketbeat.comGeneDx price target raised to $105 from $75 at Wells FargoFebruary 20 at 8:29 AM | markets.businessinsider.comAllspring Global Investments Holdings LLC Has $7.18 Million Position in GeneDx Holdings Corp. (NASDAQ:WGS)Allspring Global Investments Holdings LLC lifted its stake in shares of GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) by 50,832.8% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 90,151 shares of the company's stock after buying an additionaFebruary 20 at 3:14 AM | marketbeat.comGeneDx (NASDAQ:WGS) Hits New 52-Week High on Better-Than-Expected EarningsFebruary 20 at 1:19 AM | americanbankingnews.comGeneDx price target raised to $135 from $118 at TD CowenFebruary 19 at 8:55 PM | markets.businessinsider.com4WGS : A Closer Look at GeneDx Hldgs's Options Market DynamicsFebruary 19 at 8:55 PM | benzinga.comGeneDx (NASDAQ:WGS) Hits New 1-Year High on Strong EarningsGeneDx (NASDAQ:WGS) Reaches New 52-Week High on Earnings BeatFebruary 19 at 10:22 AM | marketbeat.comReviewing GeneDx Holdings: Exome Testing And EPIC Aura Integration Make It A GARP 'Buy'February 19 at 10:01 AM | seekingalpha.comGeneDx Holdings Corp. (NASDAQ:WGS) Q4 2024 Earnings Call TranscriptFebruary 19 at 8:26 AM | msn.comGeneDx (NASDAQ:WGS) Issues Quarterly Earnings Results, Beats Estimates By $0.66 EPSGeneDx (NASDAQ:WGS - Get Free Report) released its earnings results on Tuesday. The company reported $0.70 earnings per share for the quarter, beating analysts' consensus estimates of $0.04 by $0.66. GeneDx had a negative net margin of 31.25% and a negative return on equity of 13.35%.February 19 at 7:57 AM | marketbeat.comGeneDx Shares Surge on 4Q Revenue GrowthFebruary 18 at 6:53 PM | marketwatch.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp. - WGSFebruary 18 at 6:27 PM | prnewswire.comGeneDx reports FY24 EPS ($1.94) vs. ($7.23) last yearFebruary 18 at 8:39 AM | markets.businessinsider.comGeneDx Reports Fourth Quarter and Full Year 2024 Financial Results and Issues Guidance for Full Year 2025February 18 at 7:00 AM | businesswire.comGeneDx Holdings Corp. (NASDAQ:WGS) Given Average Rating of "Moderate Buy" by AnalystsGeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) has received an average recommendation of "Moderate Buy" from the six ratings firms that are covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating on the compFebruary 18 at 2:14 AM | marketbeat.comGeneDx launches ultrarapid whole genome sequencing for critically ill infantsFebruary 14, 2025 | msn.comGeneDx speeds up genome sequencing for NICU careFebruary 13, 2025 | msn.comGeneDx to Participate in 45th Annual TD Cowen Health Care ConferenceFebruary 13, 2025 | finance.yahoo.comLegato Capital Management LLC Has $2.13 Million Stake in GeneDx Holdings Corp. (NASDAQ:WGS)Legato Capital Management LLC lifted its stake in shares of GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) by 88.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 27,691 shares of the company's stock after purchasing anFebruary 12, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp. - WGSFebruary 11, 2025 | prnewswire.comGeneDx (WGS) to Release Quarterly Earnings on TuesdayGeneDx (NASDAQ:WGS) will be releasing earnings before the market opens on Tuesday, February 18, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=560440)February 11, 2025 | marketbeat.comGeneDx (NASDAQ:WGS) Trading 8% Higher - Still a Buy?GeneDx (NASDAQ:WGS) Trading 8% Higher - What's Next?February 10, 2025 | marketbeat.comGeneDx (NASDAQ:WGS) Stock Price Down 6.7% - Time to Sell?GeneDx (NASDAQ:WGS) Shares Down 6.7% - Time to Sell?February 8, 2025 | marketbeat.comGeneDX Holdings Q4 2024 Earnings PreviewFebruary 7, 2025 | seekingalpha.comGeneDx (NASDAQ:WGS) Stock Price Down 6.7% - Here's What HappenedGeneDx (NASDAQ:WGS) Stock Price Down 6.7% - Time to Sell?February 6, 2025 | marketbeat.comGeneDx drops after short report; Wall Street analysts defend (update)February 6, 2025 | msn.comGrizzly Research short GeneDx, says ‘actively committing widespread fraud’February 6, 2025 | markets.businessinsider.comGeneDx selloff after short report ‘appears overdone,’ says Wells FargoFebruary 5, 2025 | markets.businessinsider.comBTIG maintains GeneDx stock Buy rating, $95 target amid fraud claimFebruary 5, 2025 | msn.comGeneDx stock holds steady despite fraud allegationsFebruary 5, 2025 | msn.comGeneDx (NASDAQ:WGS) Sees Strong Trading Volume - Should You Buy?GeneDx (NASDAQ:WGS) Sees Large Volume Increase - Should You Buy?February 5, 2025 | marketbeat.comGeneDx down 3% after Grizzly Research publishes short report, alleging fraudFebruary 5, 2025 | markets.businessinsider.comGeneDx short report ‘misguided,’ buy on weakness, says Craig-HallumFebruary 5, 2025 | markets.businessinsider.comGeneDx Target of Unusually Large Options Trading (NASDAQ:WGS)GeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) saw some unusual options trading activity on Wednesday. Investors acquired 2,566 put options on the company. This represents an increase of approximately 220% compared to the average volume of 802 put options.February 5, 2025 | marketbeat.comCalamos Advisors LLC Trims Stock Position in GeneDx Holdings Corp. (NASDAQ:WGS)Calamos Advisors LLC trimmed its stake in GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) by 30.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 59,527 shares of the company's stock after selling 25,475 sharesFebruary 5, 2025 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) Shares Sold by Gagnon Advisors LLCGagnon Advisors LLC decreased its position in GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) by 26.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 187,618 shares of the company's stock after selliFebruary 1, 2025 | marketbeat.comGagnon Securities LLC Sells 182,567 Shares of GeneDx Holdings Corp. (NASDAQ:WGS)Gagnon Securities LLC trimmed its stake in shares of GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) by 33.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 359,376 shares of the company's stock after selling 18February 1, 2025 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) CFO Sells $21,582.00 in StockFebruary 1, 2025 | insidertrades.comGeneDx Holdings Corp. (NASDAQ:WGS) CFO Sells $21,582.00 in StockGeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) CFO Kevin Feeley sold 275 shares of the company's stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $78.48, for a total value of $21,582.00. Following the transaction, the chief financial officer now directly owns 2,950 shares in the company, valued at $231,516. This represents a 8.53 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.January 31, 2025 | marketbeat.comKatherine Stueland Sells 1,657 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) StockGeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) CEO Katherine Stueland sold 1,657 shares of the stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $78.48, for a total transaction of $130,041.36. Following the completion of the transaction, the chief executive officer now directly owns 3,937 shares of the company's stock, valued at approximately $308,975.76. The trade was a 29.62 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.January 31, 2025 | marketbeat.comGeneDx: Even After Up 2,700% in 2024, Upside Is Still in PlaySaying shares of GeneDx skyrocketed in 2024 may be an understatement. As a leader in its market, upside is still a legitimate possibility for this name.January 31, 2025 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) Shares Sold by Baader Bank AktiengesellschaftBaader Bank Aktiengesellschaft cut its position in GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) by 33.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 6,700 shares of the company's stock after selling 3,300 shares during the period. BaaderJanuary 31, 2025 | marketbeat.comSG Americas Securities LLC Grows Stake in GeneDx Holdings Corp. (NASDAQ:WGS)SG Americas Securities LLC lifted its stake in shares of GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) by 87.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 8,735 shares of the company's stock after purchJanuary 31, 2025 | marketbeat.comGeneDx (NASDAQ:WGS) Stock Price Down 5.6% - Here's What HappenedGeneDx (NASDAQ:WGS) Stock Price Down 5.6% - Time to Sell?January 29, 2025 | marketbeat.comCraig-Hallum Keeps Their Buy Rating on GeneDx Holdings (WGS)January 29, 2025 | markets.businessinsider.comNisa Investment Advisors LLC Grows Position in GeneDx Holdings Corp. (NASDAQ:WGS)Nisa Investment Advisors LLC grew its position in shares of GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) by 147,085.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 50,043 shares of the company's stock after acquJanuary 26, 2025 | marketbeat.comZweig DiMenna Associates LLC Acquires Shares of 309,500 GeneDx Holdings Corp. (NASDAQ:WGS)Zweig DiMenna Associates LLC purchased a new position in GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 309,500 shares of the company's stock, valued atJanuary 24, 2025 | marketbeat.com Get GeneDx News Delivered to You Automatically Sign up to receive the latest news and ratings for WGS and its competitors with MarketBeat's FREE daily newsletter. Email Address WGS Media Mentions By Week WGS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. WGS News Sentiment▼0.280.60▲Average Medical News Sentiment WGS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. WGS Articles This Week▼216▲WGS Articles Average Week Get GeneDx News Delivered to You Automatically Sign up to receive the latest news and ratings for WGS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GH News Today OPCH News Today RDNT News Today BTSG News Today SHC News Today SGRY News Today VCYT News Today LFST News Today PRVA News Today CON News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:WGS) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GeneDx Holdings Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share GeneDx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
